Fertility Treatments Market Report 2025

This Fertility Treatments market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The fertility treatments market size has grown strongly in recent years. It will grow from $18.09 billion in 2024 to $19.58 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing infertility rates, advancements in reproductive medicine, healthcare coverage, awareness and stigma reduction.

The fertility treatments market size is expected to see strong growth in the next few years. It will grow to $27.65 billion in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to delayed childbearing, expanding reproductive services, technological advancements, access to fertility services. Major trends in the forecast period include in vitro fertilization (ivf) advancements, single embryo transfer (set), telehealth and virtual consultations, fertility preservation for cancer patients.

The growing prevalence of in vitro fertilization (IVF) assisted pregnancies is expected to drive the growth of the fertility treatments market in the future. IVF-assisted pregnancies occur when an egg is fertilized outside the body, typically in a laboratory, and implanted in the uterus. The increase in IVF-assisted pregnancies is attributed to rising infertility rates, advancements in reproductive technologies, and societal shifts such as delayed parenthood and evolving family structures. Fertility treatments, including hormonal therapies and egg retrieval procedures, support IVF pregnancies by boosting egg production, improving embryo quality, and enhancing the chances of successful fertilization and implantation. For instance, in April 2024, the American Society for Reproductive Medicine, a U.S.-based nonprofit organization, reported that approximately 91,771 babies were born through IVF in 2022 in the U.S., making up 2.5% of all births that year. The number of IVF cycles performed increased by 6% to 389,993 compared to the previous year. Therefore, the rise in IVF-assisted pregnancies is driving the growth of the fertility treatments market.

The decline in fertility rates is expected to further boost the growth of the fertility treatments market. A decrease in fertility refers to individuals or couples' reduced ability to conceive and have biological children, often caused by factors such as age, medical conditions, lifestyle choices, or environmental influences. Fertility treatments, such as intrauterine insemination (IUI) and in vitro fertilization (IVF), help increase the chances of conception for those struggling with fertility issues. For example, in April 2024, the Centers for Disease Control and Prevention, a U.S.-based national public health agency, reported that the number of births in the United States in 2023 was 3,591,328, reflecting a 2% decrease compared to 2022. As such, the rising infertility rate is driving the growth of the fertility treatments market.

A notable trend in the fertility treatments market is the development of innovative techniques to treat infertility within the human body. One such example is INVOcell, an alternative to traditional IVF that uses the woman's body to support fertilization, eliminating the need for a laboratory incubator. INVOcell, developed by INVO Bioscience in Medford, Massachusetts, costs around $6,800, including medication. Although IVF typically generates more quality embryos, the birth rates achieved with INVOcell are similar to those of traditional IVF. Such innovations are reshaping the landscape of fertility treatments and addressing cost and success rate challenges.

Major companies operating in the fertility treatments market are also utilizing artificial intelligence (AI) technology to enhance IVF treatments. AI has the potential to revolutionize fertility care by providing personalized, data-driven insights for clinicians and patients. For example, in October 2022, Alife Health, a U.S.-based healthcare company, introduced new artificial intelligence software designed to improve IVF treatment outcomes, reduce costs, and optimize clinical decision-making at critical stages of the IVF process.

In August 2022, CCRM Fertility, an American fertility treatment company, acquired the Institute for Reproductive Medicine & Sciences (IRMS) to enhance its offerings and expand its presence across 11 major metropolitan areas with 34 locations in the United States and Canada. This strategic acquisition added proprietary reproductive medicine solutions to CCRM's portfolio, strengthening its position in the fertility treatment market.

Fertility treatment is a medical intervention designed to enhance the reproductive capabilities of individuals, both men and women, who are experiencing infertility. These treatments often involve the use of hormone and ovulation-supporting medications, sometimes coupled with minor surgical procedures.

The primary product categories associated with fertility treatment include reagents and equipment. Reagents are substances or compounds that are added to a system to induce a chemical reaction or to assess the occurrence of a reaction. Fertility treatments are typically carried out on both male and female patients and are offered in a variety of healthcare settings, including fertility clinics, hospitals, surgical centers, and clinical research institutes. These facilities provide a range of medical interventions to address infertility and improve the chances of conceiving offspring.

The fertility treatment market research report is one of a series of new reports that provides fertility treatment market statistics, including fertility treatment industry global market size, regional shares, competitors with a fertility treatment market share, detailed fertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the fertility treatment industry. This fertility treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the fertility treatments market include Apollo Hospitals Enterprise Ltd., Care Fertility Group Limited, Genea Limited, Johns Hopkins Health System Corp., Medicover AB, Monash IVF Group, Progyny Inc., Vitrolife AB, Carolinas Fertility Institute PLLC, OvaScience Inc., Xytex Cryo International Ltd., Merck Group, Cook Group Incorporated, CooperSurgical Inc., Instituto Bernabeu, INVO Bioscience Inc., Cooper Companies Inc., Virtus Health Ltd., CryoChoice LLC, Millendo Therapeutics Inc., FUJIFILM Irvine Scientific Inc., LABOTECT GMBH, Fertility Focus Limited, Olympus Corporation, Irvine Scientific sales Company Inc., Ferring Pharmaceuticals Inc., Prelude Fertility Inc., Boston IVF, RMA Fertility Clinics, Shady Grove Fertility, CCRM Management Company LLC, IVIRMA Global, CARE Fertility.

North America was the largest region in the fertility treatment market in 2024. Western Europe was the second largest region in the fertility treatment market. The regions covered in the fertility treatments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fertility treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fertility treatment market includes revenues earned by entities by providing medicinal services, surgical services, and assisted services such as in vitro fertilization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.